Authors:
Hambley, TW
Jackson, TW
Kojima, M
Knott, RB
Lambrecht, RM
Turner, P
Citation: Tw. Hambley et al., 6,6,9,9-tetramethyl-1,2,5,6,9,9a-hexahydro-imidazo[2,1-d][1,2,5]dithiazepin-1-ium triiodide, ACT CRYST E, 57, 2001, pp. o315-o317
Authors:
Hambley, TW
Lindoy, LF
Reimers, JR
Turner, P
Wei, G
Widmer-Cooper, AN
Citation: Tw. Hambley et al., Macrocyclic ligand design. X-Ray, DFT and solution studies of the effect of N-methylation and N-benzylation of 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane on its affinity for selected transition and post-transition metal ions, J CHEM S DA, (5), 2001, pp. 614-620
Authors:
Habtemariam, A
Parkinson, JA
Margiotta, N
Hambley, TW
Parsons, S
Sadler, PJ
Citation: A. Habtemariam et al., Structure and dynamics of a platinum(II) aminophosphine complex and its nucleobase adducts, J CHEM S DA, (4), 2001, pp. 362-372
Authors:
Cham, ST
Diakos, CI
Ellis, LT
Fenton, RR
Munk, VP
Messerle, BA
Hambley, TW
Citation: St. Cham et al., Isomer formation in the binding of [PtCl2(cis-cyclohexane-1,3-diamine)] tooligonucleotides and the X-ray crystal structure of [PtCl2(cis-cyclohexane-1,3-diamine)]center dot dimethylformamide, J CHEM S DA, (19), 2001, pp. 2769-2774
Authors:
Hambley, TW
Ling, ECH
Munk, VP
Davies, MS
Citation: Tw. Hambley et al., Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: comparison with cis-[PtCl2(NH3)(2)] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies, J BIOL I CH, 6(5-6), 2001, pp. 534-542
Authors:
Morgan, YR
Turner, P
Kennedy, BJ
Hambley, TW
Lay, PA
Biffin, JR
Regtop, HL
Warwick, B
Citation: Yr. Morgan et al., Preparation and characterization of dinuclear copper-indomethacin anti-inflammatory drugs, INORG CHIM, 324(1-2), 2001, pp. 150-161
Authors:
Weder, JE
Hambley, TW
Kennedy, BJ
Lay, PA
Foran, GJ
Rich, AM
Citation: Je. Weder et al., Determination of the structures of antiinflammatory copper(II) dimers of indomethacin by multiple-scattering analyses of X-ray absorption fine structure data, INORG CHEM, 40(6), 2001, pp. 1295-1302
Authors:
Headlam, HA
Weeks, CL
Turner, P
Hambley, TW
Lay, PA
Citation: Ha. Headlam et al., Dinuclear chromium(V) amino acid complexes from the reduction of chromium(VI) in the presence of amino acid ligands: XAFS characterization of a chromium(V) amino acid complex, INORG CHEM, 40(20), 2001, pp. 5097-5105
Authors:
Davies, MS
Diakos, CI
Messerle, BA
Hambley, TW
Citation: Ms. Davies et al., Structure, stability, and interconversion barriers of the rotamers of cis-[(PtCl2)-Cl-II(quinoline)(2)] and cis-[(PtCl2)-Cl-II(3-bromoquinoline) (quinoline)] from X-ray crystallography, NMR spectroscopy and molecular mechanics evidence, INORG CHEM, 40(13), 2001, pp. 3048-3054
Citation: Pn. Wong et al., Oxidation of [(PtCl2)-Cl-II(ethane-1,2-diamine-N,N '-dicarboxylic acid)] and ligand ring closure in the platinum(IV) oxidation state, AUST J CHEM, 54(5), 2001, pp. 303-306
Authors:
Giannikopoulos, G
Carter, J
Fenton, RR
Hambley, TW
Citation: G. Giannikopoulos et al., The synthesis of ethane-1,2-diamine-N,N '-bis(methylenephosphonic) acid and its platinum(II) complex, bis{ethane-1,2-diamine-N,N '-bis(methylenephosphonato)}platinum(II), AUST J CHEM, 54(2), 2001, pp. 127-130
Citation: Tw. Hambley et al., Increased targeting of adenine-rich sequences by (2-amino-2-methyl 3-butanone oxime)dichloroplatinum(II) and investigations into its low cytotoxicity, J BIOL I CH, 5(6), 2000, pp. 675-681
Authors:
Cusack, RM
Grondahl, L
Abbenante, G
Fairlie, DP
Gahan, LR
Hanson, GR
Hambley, TW
Citation: Rm. Cusack et al., Conformations of cyclic octapeptides and the influence of heterocyclic ring constraints upon calcium binding, J CHEM S P2, (2), 2000, pp. 323-331
Citation: Ms. Davies et al., Rates of platination of -AG- and -GA- containing double-stranded oligonucleotides: effect of chloride concentration, J INORG BIO, 79(1-4), 2000, pp. 167-172
Authors:
Ling, ECH
Allen, GW
Vickery, K
Hambley, TW
Citation: Ech. Ling et al., The preparation, characterisation, and DNA adduct profile of 2-amino-2-methyl-3-butanoneoximedichloroplatinum(II), a platinum(II) complex designed tobind to GpA sequences of DNA, J INORG BIO, 78(1), 2000, pp. 55-62
Authors:
Codd, R
Levina, A
Zhang, LB
Hambley, TW
Lay, PA
Citation: R. Codd et al., Characterization and X-ray absorption spectroscopic studies of bis[quinato(2-)]oxochromate(V), INORG CHEM, 39(5), 2000, pp. 990-997
Citation: Ms. Davies et al., Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: Improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA, INORG CHEM, 39(25), 2000, pp. 5603-5613
Authors:
Screnci, D
McKeage, MJ
Galettis, P
Hambley, TW
Palmer, BD
Baguley, BC
Citation: D. Screnci et al., Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs, BR J CANC, 82(4), 2000, pp. 966-972